Mismatched transplants for refractory lymphoma?

被引：1

作者：

Falkenburg, JHF ^{[1
]}

Kluin-Nelemans, HC ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Haematol, NL-2300 RC Leiden, Netherlands

来源：

LANCET | 1999年 / 353卷 / 9166期

关键词：

D O I：

10.1016/S0140-6736(98)00402-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1725 / 1726

页数：2

共 10 条

[1] MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE [J].

BACHARLUSTIG, E ;

RACHAMIM, N ;

LI, HW ;

LAN, FS ;

REISNER, Y .

NATURE MEDICINE, 1995, 1 (12) :1268-1273

[2] Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [J].

Collins, RH ;

Shpilberg, O ;

Drobyski, WR ;

Porter, DL ;

Giralt, S ;

Champlin, R ;

Goodman, SA ;

Wolff, SN ;

Hu, W ;

Verfaillie, C ;

List, A ;

Dalton, W ;

Ognoskie, N ;

Chetrit, A ;

Antin, JH ;

Nemunaitis, J .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :433-444

[3] Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia [J].

Falkenburg, JHF ;

Smit, WM ;

Willemze, R .

IMMUNOLOGICAL REVIEWS, 1997, 157 :223-230

[4]

FISHER RI, 1982, CANCER RES, V42, P2465

[5] Human minor histocompatibility antigens: New concepts for marrow transplantation and adoptive immunotherapy [J].

Goulmy, E .

IMMUNOLOGICAL REVIEWS, 1997, 157 :125-140

[6] Transplant-lite:: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies [J].

Khouri, IF ;

Keating, M ;

Körbling, M ;

Przepiorka, D ;

Anderlini, P ;

O'Brien, S ;

Giralt, S ;

Ippoliti, C ;

von Wolff, B ;

Gajewski, J ;

Donato, M ;

Claxton, D ;

Ueno, N ;

Andersson, B ;

Gee, A ;

Champlin, R .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2817-2824

[7] MACOP-B CHEMOTHERAPY FOR THE TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA [J].

KLIMO, P ;

CONNORS, JM .

ANNALS OF INTERNAL MEDICINE, 1985, 102 (05) :596-602

[8] GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS [J].

KOLB, HJ ;

SCHATTENBERG, A ;

GOLDMAN, JM ;

HERTENSTEIN, B ;

JACOBSEN, N ;

ARCESE, W ;

LJUNGMAN, P ;

FERRANT, A ;

VERDONCK, L ;

NIEDERWIESER, D ;

VANRHEE, F ;

MITTERMUELLER, J ;

DEWITTE, T ;

HOLLER, E ;

ANSARI, H .

BLOOD, 1995, 86 (05) :2041-2050

[9] Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases [J].

Slavin, S ;

Nagler, A ;

Naparstek, E ;

Kapelushnik, Y ;

Aker, M ;

Cividalli, G ;

Varadi, G ;

Kirschbaum, M ;

Ackerstein, A ;

Samuel, S ;

Amar, A ;

Brautbar, C ;

Ben-Tal, O ;

Eldor, A ;

Or, R .

BLOOD, 1998, 91 (03) :756-763

[10] T cells recognizing leukemic CD34+ progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation [J].

Smit, WM ;

Rijnbeek, M ;

van Bergen, CAM ;

Fibbe, WE ;

Willemze, R ;

Falkenburg, JHF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) :10152-10157

← 1 →